With the regulatory milestone of the first accelerated FDA approval of a gene therapy treatment for Duchenne Muscular Dystrophy, more therapies progressing towards later stage development and the gene therapy landscape exponentially growing, the industry need for developing effective analytical strategies through understanding updates advancements in analytical technologies and services is more important than ever.
The 5th Annual Gene Therapy Analytical Development Summit united 400+ analytical, process development, quality, CMC, and regulatory experts in-person in Boston. If you provide analytical services or technologies that would benefit our niche industry audience, now is the time to secure new business and form connections with top biopharma companies seeking analytical solutions to progress their products to market.
Gene Therapy Analytical Biopharma is Seeking:
Assay providers to measure product potency, infectivity and expression
Sequencing and screening technologies to quantitively characterize product genome integrity
Automation and platform assay solutions to improve sample throughput analysis and efficiency
Novel technologies to define product biophysical properties, including empty-full characterization
CROs and CDMOs with services specializing in the gene therapy analytics and manufacturing
And more!
Why Partner?
Showcase your solutions to a niche, focused group of analytical experts from the leading companies in the gene therapy field
Elevate your company’s standing in the field and demonstrate your ability to keep up with high pressured timelines
Stand out from your competitors by demonstrating to your clients how your experience and specific analytical technologies can meet their demands
“The Gene Therapy Analytical Development Summit is a wonderful opportunity to hear about the most current trends in the world of Gene Therapy, and connect with all of our industry experts. The past summits have been very informative, providing very interactive workshops and presentations, and I’m very excited to attend again!”
2022 attendee, Sarepta Therapeutics
